S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
NYSE:OGEN

Oragenics (OGEN) Stock Price, News & Analysis

$1.44
+0.04 (+2.86%)
(As of 03/28/2024 ET)
Today's Range
$1.40
$1.47
50-Day Range
$1.38
$6.14
52-Week Range
$1.26
$7.74
Volume
25,646 shs
Average Volume
86,869 shs
Market Capitalization
$6.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Oragenics

Oragenics, Inc., a development-stage company, engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

OGEN Stock Price History

OGEN Stock News Headlines

Oragenics Appoints Kelly As Chief Medical Officer
This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
15 Highest Quality Probiotics For Gut Health
Oragenics Announces Closing of Public Offering
Oragenics announces public stock offering
Why Is Oragenics (OGEN) Stock Down 45% Today?
A lot of people are making this costly mistake
You may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
Oragenics Announces Pricing of Public Offering
Oragenics Shares Fall After Proposed Public Offering
Oragenics Announces Proposed Public Offering
Oragenics, Inc. Announces Leadership Transition
OGEN, RLMD and ATXI among mid-day movers
Oragenics, Inc. (UAV.F)
Oragenics Issues Update to Shareholders
See More Headlines
Receive OGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/16/2021
Today
3/29/2024
Next Earnings (Estimated)
4/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Employees
6
Year Founded
N/A

Profitability

Net Income
$-14,290,000.00
Pretax Margin
-26,700.00%

Debt

Sales & Book Value

Annual Sales
$130,000.00
Book Value
$5.64 per share

Miscellaneous

Free Float
3,379,000
Market Cap
$6.45 million
Optionable
N/A
Beta
0.29
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Charles L. Pope CPA (Age 72)
    Executive Chairman
    Comp: $82.5k
  • Mr. Joseph Michael Redmond (Age 63)
    President & Interim Principal Executive Officer
  • Ms. Janet Huffman (Age 52)
    CFO, Secretary & Treasurer
  • Dr. James P. Kelly M.A.
    M.D., Chief Medical Officer & Member of Scientific Advisor

OGEN Stock Analysis - Frequently Asked Questions

How have OGEN shares performed in 2024?

Oragenics' stock was trading at $6.1382 on January 1st, 2024. Since then, OGEN stock has decreased by 76.5% and is now trading at $1.44.
View the best growth stocks for 2024 here
.

When is Oragenics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, April 12th 2024.
View our OGEN earnings forecast
.

How were Oragenics' earnings last quarter?

Oragenics, Inc. (NYSE:OGEN) posted its earnings results on Monday, August, 16th. The company reported ($1.80) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.40) by $0.60.

When did Oragenics' stock split?

Oragenics's stock reverse split before market open on Monday, January 23rd 2023. The 1-60 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of Oragenics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oragenics investors own include Yunji (YJ), MFA Financial (MFA) and

How do I buy shares of Oragenics?

Shares of OGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:OGEN) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners